Frank T. Edelmann
Elite in Heart Failure with Preserved Ejection Fraction (HFpEF)

Frank T. Edelmann

Potsdamer Str. 58, 
Berlin, BE, DE 
Elite in Heart Failure with Preserved Ejection Fraction (HFpEF)
Potsdamer Str. 58, 
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Frank Edelmann practices in Berlin, Germany. Mr. Edelmann is rated as an Elite expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atrial Fibrillation, and Tricuspid Regurgitation.

His clinical research consists of co-authoring 248 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 100 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Potsdamer Str. 58, Berlin, BE 10785, Germany
Other Locations
Robert Koch Str. 40, Goettingen, NI 37075, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Enrollment Status: Completed
Publish Date: September 17, 2021
Intervention Type: Device, Other
Study Phase: Not Applicable
Revacept, a Novel Inhibitor of Platelet Adhesion in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Interventions: a Phase II, Multicentre, Randomised, Double-blind and Placebo-controlled Study
Revacept, a Novel Inhibitor of Platelet Adhesion in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Interventions: a Phase II, Multicentre, Randomised, Double-blind and Placebo-controlled Study
Enrollment Status: Completed
Publish Date: April 20, 2020
Intervention Type: Drug
Study Phase: Phase 2
Optical Coherence Tomography in Acute Coronary Syndrome
Optical Coherence Tomography in Acute Coronary Syndrome
Enrollment Status: Unknown
Publish Date: July 23, 2019
Telemedical Interventional Management in Heart Failure II
Telemedical Interventional Management in Heart Failure II
Enrollment Status: Completed
Publish Date: August 03, 2018
Intervention Type: Other, Device
Study Phase: Phase 3
View 3 Less Clinical Trials

248 Total Publications

Transcatheter mitral repair in patients with symptomatic moderate functional mitral regurgitation: 1-year outcomes from the MiCLASP study.
Transcatheter mitral repair in patients with symptomatic moderate functional mitral regurgitation: 1-year outcomes from the MiCLASP study.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: August 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Edelmann's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile